These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10155301)

  • 1. Quality-of-Life measurements for patients taking which drugs? The clinical PCASEE perspective.
    Bech P
    Pharmacoeconomics; 1995 Feb; 7(2):141-51. PubMed ID: 10155301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antihypertensive agents on quality of life in the elderly.
    Fogari R; Zoppi A
    Drugs Aging; 2004; 21(6):377-93. PubMed ID: 15084140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life evaluation of antihypertensive drugs.
    Bulpitt CJ; Fletcher AE
    Pharmacoeconomics; 1992 Feb; 1(2):95-102. PubMed ID: 10146939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
    Yodfat Y; Bar-On D; Amir M; Cristal N
    J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hypertension in the elderly and its effects on the QOL].
    Mikami H
    Nihon Rinsho; 2005 Jun; 63(6):1096-100. PubMed ID: 15948397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social functioning: should it become an endpoint in trials of antidepressants?
    Bech P
    CNS Drugs; 2005; 19(4):313-24. PubMed ID: 15813645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials.
    Côté I; Grégoire JP; Moisan J
    Pharmacoeconomics; 2000 Nov; 18(5):435-50. PubMed ID: 11151397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
    Cohen RM; Greenberg JM; IsHak WW
    JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social functioning and the treatment of depression.
    Weissman MM
    J Clin Psychiatry; 2000; 61 Suppl 1():33-8. PubMed ID: 10703761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of antihypertensive drug therapy on quality of life.
    Scherger JE
    Postgrad Med; 2000 Oct; 108(5 Suppl):25-9. PubMed ID: 19667538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in quality of life outcomes among depressed spinal cord injury trial participants.
    Tate DG; Forchheimer M; Bombardier CH; Heinemann AW; Neumann HD; Fann JR
    Arch Phys Med Rehabil; 2015 Feb; 96(2):340-8. PubMed ID: 25450124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
    Poon IO
    Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective therapy for hypertension.
    Barrie W
    West J Med; 1996 Apr; 164(4):303-9. PubMed ID: 8732729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of subjective quality of life in depressed patients: the role of self-esteem, response styles, and social support.
    Kuehner C; Buerger C
    J Affect Disord; 2005 Jun; 86(2-3):205-13. PubMed ID: 15935240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is cost-effectiveness analysis?
    Evans DB
    Med J Aust; 1990 Aug; 153(S1):S7-9. PubMed ID: 2116585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
    Pradelli L; Iannazzo S; Zaniolo O
    Am J Cardiovasc Drugs; 2009; 9(6):383-92. PubMed ID: 19929036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant improvement in the quality of life of Brazilian depressed outpatients 12 weeks following the start of antidepressants.
    Berlim MT; Pargendler J; Brenner J; Fleck MP
    Psychiatry Res; 2007 Dec; 153(3):253-9. PubMed ID: 17675247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.